Sitting in quite a few sessions at the American Association for Cancer Research (AACR) over the last few days and listening to some very encouraging results. There will be plenty of press around these releases; for patients and caregivers, trial results can be as confusing as they are encouraging. For anyone who finds or keeps up with these advances, remember that trial results are often communicated in a language for regulatory approval (i.e. The FDA) and investors (i.e. Wall Street). Often they are not apples to apples comparisons from a patient view; as you consider current trials and try and interpret trial results, make sure you are discussing trial results in the context of information that contribute to finding the best treatment plan for an individual, not as a top-down list of best/next best etc... treatment options.
Clinical Trial Updates coming from th... - Understanding Cli...
Clinical Trial Updates coming from the annual AACR meeting
Written by
TSharpe2
Ambassador
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Good words of advice TSharpe2! I would also add that more and more companies are providing results of their trials in lay language summaries, so that more patients and caregivers can understand the reports. Hope to keep seeing more of this practice across the industry!
Not what you're looking for?
You may also like...
Clinical Trial Care and Compensation
We know that when considering participating in a clinical trial there can be a lot of financial...
Why Do People Decide To Participate In Clinical Trials and Why Do People Decide To Continue In A Trial?
I would like to know why people decide to participate in a trial, especially when there are still...
Reservations about participating in Clinical Trials...
After reading the book "Bad Pharma" I developed some concerns about participating in Clinical...
Cabozantinib Clinical Trial
Hi,
I'm a 60 yo male with Advanced PC. Diagnosed in 2012. Underwent Proton Therapy at MD...
Four years & 70 anti-PD-1 infusions on clinical trial
Hey all - just finished my 70th anti-PD-1 infusion over 4 years on the KEYNOTE-002 trial; although...